BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33755132)

  • 1. Optimizing Measurement and Interpretation of the G6PD/Hb Ratio.
    Higgins V; Cheng PL; Selvaratnam R; Brinc D
    J Appl Lab Med; 2021 Sep; 6(5):1251-1263. PubMed ID: 33755132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluations of newborn screening program performance and enzymatic diagnosis of glucose-6-phosphate dehydrogenase deficiency in Guangzhou].
    Tang F; Huang YL; Jiang X; Jia XF; Li B; Feng Y; Chen QY; Tang CF
    Zhonghua Er Ke Za Zhi; 2018 May; 56(5):359-363. PubMed ID: 29783822
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency.
    Taylor WRJ; Kheng S; Muth S; Tor P; Kim S; Bjorge S; Topps N; Kosal K; Sothea K; Souy P; Char CM; Vanna C; Ly P; Khieu V; Christophel E; Kerleguer A; Pantaleo A; Mukaka M; Menard D; Baird JK
    J Infect Dis; 2019 Oct; 220(11):1750-1760. PubMed ID: 31549159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis.
    Pfeffer DA; Ley B; Howes RE; Adu P; Alam MS; Bansil P; Boum Y; Brito M; Charoenkwan P; Clements A; Cui L; Deng Z; Egesie OJ; Espino FE; von Fricken ME; Hamid MMA; He Y; Henriques G; Khan WA; Khim N; Kim S; Lacerda M; Lon C; Mekuria AH; Menard D; Monteiro W; Nosten F; Oo NN; Pal S; Palasuwan D; Parikh S; Pitaloka Pasaribu A; Poespoprodjo JR; Price DJ; Roca-Feltrer A; Roh ME; Saunders DL; Spring MD; Sutanto I; Thriemer K; Weppelmann TA; von Seidlein L; Satyagraha AW; Bancone G; Domingo GJ; Price RN
    PLoS Med; 2020 May; 17(5):e1003084. PubMed ID: 32407380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks of Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficient Infants Exposed to Chlorproguanil-Dapsone, Mefloquine and Sulfadoxine-Pyrimethamine as Part of Intermittent Presumptive Treatment of Malaria in Infants.
    Poirot E; Vittinghoff E; Ishengoma D; Alifrangis M; Carneiro I; Hashim R; Baraka V; Mosha J; Gesase S; Chandramohan D; Gosling R
    PLoS One; 2015; 10(11):e0142414. PubMed ID: 26599634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-inheritance of glucose-6-phosphate dehydrogenase deficiency mutations and hemoglobin E in a Kachin population in a malaria-endemic region of Southeast Asia.
    Deng Z; Yang F; Bai Y; He L; Li Q; Wu Y; Luo L; Li H; Ma L; Yang Z; He Y; Cui L
    PLoS One; 2017; 12(5):e0177917. PubMed ID: 28531196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative neonatal glucose-6-phosphate dehydrogenase screening: distribution, reference values, and classification by phenotype.
    Algur N; Avraham I; Hammerman C; Kaplan M
    J Pediatr; 2012 Aug; 161(2):197-200. PubMed ID: 22494872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
    Shekalaghe SA; ter Braak R; Daou M; Kavishe R; van den Bijllaardt W; van den Bosch S; Koenderink JB; Luty AJ; Whitty CJ; Drakeley C; Sauerwein RW; Bousema T
    Antimicrob Agents Chemother; 2010 May; 54(5):1762-8. PubMed ID: 20194698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of Glucose-6-Phosphate Dehydrogenase Deficiency: 5 Years Retrospective Egyptian Study.
    Hagag AA; Badraia IM; Elfarargy MS; Abd Elmageed MM; Abo-Ali EA
    Endocr Metab Immune Disord Drug Targets; 2018 Feb; 18(2):155-162. PubMed ID: 28982343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of hemolysis in Plasmodium vivax malaria patients receiving standard primaquine treatment in a population with high prevalence of G6PD deficiency.
    Liu H; Zeng W; Malla P; Wang C; Lakshmi S; Kim K; Menezes L; Yang Z; Cui L
    Infection; 2023 Feb; 51(1):213-222. PubMed ID: 35976559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review and drug therapy implications of glucose-6-phosphate dehydrogenase deficiency.
    Belfield KD; Tichy EM
    Am J Health Syst Pharm; 2018 Feb; 75(3):97-104. PubMed ID: 29305344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of glucose-6-phosphate dehydrogenase cut-off values in a Tunisian population.
    Laouini N; Sahli CA; Jouini L; Haloui S; Fredj SH; Daboubi R; Siala H; Ouali F; Becher M; Toumi N; Bibi A; Messsaoud T
    Clin Chem Lab Med; 2017 Jul; 55(8):1193-1201. PubMed ID: 28099116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human G6PD for quality control and quality assurance of novel point-of-care diagnostics for G6PD deficiency.
    Kahn M; LaRue N; Zhu C; Pal S; Mo JS; Barrett LK; Hewitt SN; Dumais M; Hemmington S; Walker A; Joynson J; Leader BT; Van Voorhis WC; Domingo GJ
    PLoS One; 2017; 12(5):e0177885. PubMed ID: 28552983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of optimal cutoff value to accurately identify glucose-6-phosphate dehydrogenase-deficient heterozygous female neonates.
    Miao JK; Chen QX; Bao LM; Huang Y; Zhang J; Wan KX; Yi J; Wang SY; Zou L; Li TY
    Clin Chim Acta; 2013 Sep; 424():131-5. PubMed ID: 23680071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification to reporting of qualitative fluorescent spot test results improves detection of glucose-6-phosphate dehydrogenase (G6PD)-deficient heterozygote female newborns.
    Nadarajan V; Shanmugam H; Sthaneshwar P; Jayaranee S; Sultan KS; Ang C; Arumugam S
    Int J Lab Hematol; 2011 Oct; 33(5):463-70. PubMed ID: 21501392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comparison of Three Quantitative Methods to Estimate G6PD Activity in the Chittagong Hill Tracts, Bangladesh.
    Ley B; Alam MS; O'Donnell JJ; Hossain MS; Kibria MG; Jahan N; Khan WA; Thriemer K; Chatfield MD; Price RN; Richards JS
    PLoS One; 2017; 12(1):e0169930. PubMed ID: 28121993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point-of-Care Quantitative Measure of Glucose-6-Phosphate Dehydrogenase Enzyme Deficiency.
    Bhutani VK; Kaplan M; Glader B; Cotten M; Kleinert J; Pamula V
    Pediatrics; 2015 Nov; 136(5):e1268-75. PubMed ID: 26459646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reference and point-of-care testing for G6PD deficiency: Blood disorder interference, contrived specimens, and fingerstick equivalence and precision.
    Pal S; Myburgh J; Bansil P; Hann A; Robertson L; Gerth-Guyette E; Ambler G; Bizilj G; Kahn M; Zobrist S; Manis MR; Styke NA; Allan V; Ansbro R; Akingbade T; Bryan A; Murphy SC; Kublin JG; Layton M; Domingo GJ
    PLoS One; 2021; 16(9):e0257560. PubMed ID: 34543346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-6-phosphate dehydrogenase deficiency neonatal screening: preliminary evidence that a high percentage of partially deficient female neonates are missed during routine screening.
    Reclos GJ; Hatzidakis CJ; Schulpis KH
    J Med Screen; 2000; 7(1):46-51. PubMed ID: 10807147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency in Brazil.
    Zobrist S; Brito M; Garbin E; Monteiro WM; Clementino Freitas S; Macedo M; Soares Moura A; Advani N; Kahn M; Pal S; Gerth-Guyette E; Bansil P; Domingo GJ; Pereira D; Lacerda MV
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009649. PubMed ID: 34383774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.